Diagnostic and Statistical Manual: Difference between revisions
From ProleWiki, the proletarian encyclopedia
More languages
More actions
(→Financial conflicts of interest: Added a source.) |
mNo edit summary |
||
Line 8: | Line 8: | ||
===Financial conflicts of interest=== | ===Financial conflicts of interest=== | ||
A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.<ref name='10.1159/000091772'>{{Citation|doi=10.1159/000091772|author=Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L.|year=2006|title=Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry|journal=Psychotherapy and Psychosomatics|volume=75( | A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.<ref name='10.1159/000091772'>{{Citation|doi=10.1159/000091772|author=Cosgrove, L., Krimsky, S., Vijayaraghavan, M., & Schneider, L.|year=2006|title=Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry|journal=Psychotherapy and Psychosomatics|volume=75(3)|page=154–160}}</ref> | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] |
Revision as of 15:14, 4 November 2022
The Diagnostic and Statistical Manual of Mental Disorders (abbreviation: DSM) is a publication of works that classify psychiatric disorders. The DSM is created and published by the American Psychiatric Association.
Criticisms
There are a number of different criticisms that have been leveled against the DSM and its usefulness as a diagnostic manual.
Lack of Objective Analysis
The DSM does not require the use of objective analysis.
Financial conflicts of interest
A large portion of the designing staff of the DSM-IV had received funding, in some method, from pharmaceutical companies.[1]